Oral medications patients take when symptoms first appear are being tested, but initial results are not expected for several months
Methotrexate May Impair Immune Response to mRNA COVID-19 Vaccine
Poorer humoral, cellular immune responses seen in patients receiving methotrexate for immune-mediated inflammatory disease
Meds Used for Hospitalized COVID-19 Patients Shifted Over 2020
Dexamethasone and remdesivir use grew substantially, while azithromycin and hydroxychloroquine both declined from early peaks
Infliximab May Reduce Immunogenicity to SARS-CoV-2 Vaccine
Antibody concentrations lower in infliximab-treated individuals with IBD receiving single dose of BNT162b2 or ChAdOx1 nCoV-19 vaccine
COVID-19 Pill Could Be Available Later This Year: Pfizer CEO
If clinical trials are successful and the FDA approves the drug, it could be available across the United States later in 2021
Restrictions on Access to Abortion Pill Will Be Lifted During Pandemic
Decision means that health care providers in some states will be able to prescribe mifepristone via telemedicine and mail the pills to patients
Experts Address Osteoporosis Therapy and COVID-19 Vaccination
Oral bisphosphonates should be continued without delay; one-week interval recommended between IV bisphosphonate and vaccine
Remdesivir Linked to Faster Clinical Improvement of COVID-19
Findings seen in mainly non-White race/ethnicity patients hospitalized with confirmed SARS-CoV-2 infection
Infliximab May Impede Serologic Response to SARS-CoV-2
Concomitant immunomodulator use further blunted antibody responses to SARS-CoV-2 among infliximab-treated IBD patients
Prescribing of Psychotropic Meds Up in Nursing Homes During COVID-19
Compared with Jan. to Feb. 2020, prescriptions for antipsychotics, antidepressants, trazodone up from March to Sept. 2020